Renal cell carcinomas and pancreatic adenocarcinomas produce nidogen in vitro and in vivo.
The production of nidogen by four renal cell carcinoma (RCC) and three pancreatic adenocarcinoma (PAc) cell lines has been studied in cell culture and in xenografted tumours in nude mice. In RCC cells, immunoreactivity for nidogen was seen only after exposure to monensin to induce cytoplasmic accumulation of secretory proteins. In PAc cells, immunoreaction was also detectable in control cells. Immunoblotting of control and monensin-exposed cells and immunoprecipitation of culture media of radioactively labelled cells demonstrated the production of nidogen polypeptide of Mr ca. 150000 by six of the seven cell lines. Basement membranes (BMs) and stroma of the xenografted tumours derived from these six cell lines demonstrated immunoreactivity for both human and mouse nidogen, as revealed with species-specific antibodies. The ability of the cells to produce nidogen in vitro and deposit in vivo was positively correlated with high histological grade of the xenografted tumours, although the small number of cell lines studied calls for further studies to confirm this. The distribution of nidogen in human RCC and PAc specimens was also studied by immunohistochemistry. There was strong immunoreactivity for nidogen in tumour stroma, BM of carcinoma cell nests, and endothelial basal lamina, but no conclusions could be drawn regarding histological grade and immunostaining patterns, because stromal production could not be ruled out. The results show that nidogen is produced by human carcinoma cells both in vitro and in vivo.
Oivula
J
J
Department of Anatomy, Institute of Biomedicine, P.O. Box 9 (Siltavuorenpenger 20A), FIN-00014 University of Helsinki, Helsinki, Finland. Jan.Oivula@helsinki.fi
Lohi
J
J
Tani
T
T
Kangas
L
L
Kiviluoto
T
T
Kivilaakso
E
E
Butkowski
R
R
Virtanen
I
I
D000230:Adenocarcinoma / Q000378:metabolism*; D000818:Animals; D001485:Basement Membrane / Q000378:metabolism; D002292:Carcinoma, Renal Cell / Q000378:metabolism*; D005455:Fluorescent Antibody Technique; D006801:Humans; D007124:Immunoenzyme Techniques; D007680:Kidney Neoplasms / Q000378:metabolism*; D008562:Membrane Glycoproteins / Q000096:biosynthesis*; D051379:Mice; D008819:Mice, Nude; D009363:Neoplasm Proteins / Q000096:biosynthesis*; D009368:Neoplasm Transplantation; D010190:Pancreatic Neoplasms / Q000378:metabolism*; D014183:Transplantation, Heterologous; D014407:Tumor Cells, Cultured
D008562:Membrane Glycoproteins; D009363:Neoplasm Proteins; C029967:nidogen